ENGIVYV

Serial Number 79419841
Registration 7854371
700

Registration Progress

Application Filed
Feb 12, 2025
Under Examination
Approved for Publication
May 20, 2025
Published for Opposition
May 20, 2025
Registered
Jul 8, 2025

Basic Information

Serial Number
79419841
Registration Number
7854371
Filing Date
February 12, 2025
Registration Date
July 8, 2025
Published for Opposition
May 20, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 8, 2025
Registration
Registered
Classes
005

Rights Holder

NOVARTIS AG

25
Address
CH-4002 Basel
CH

Ownership History

NOVARTIS AG

Original Applicant
25
CH

NOVARTIS AG

Owner at Publication
25
CH

NOVARTIS AG

Original Registrant
25
CH

Legal Representation

Attorney
Maury M. Tepper, III

USPTO Deadlines

Next Deadline
2190 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-07-08)
Due Date
July 08, 2031
Grace Period Ends
January 08, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

16 events
Date Code Type Description
Jul 8, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 8, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
May 20, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 20, 2025 PUBO A PUBLISHED FOR OPPOSITION
May 14, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 19, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 19, 2025 DOCK D ASSIGNED TO EXAMINER
Apr 4, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 4, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 4, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 4, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 4, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 28, 2025 MAFR O APPLICATION FILING RECEIPT MAILED
Mar 28, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 25, 2025 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 20, 2025 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Detailed Classifications

Class 005
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification

International Classes
005